Author:
Anderson Peter L.,Fletcher Courtney V.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Centers for Disease Control and Prevention: Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998, 47(RR-5):1–41. Tabled source of information for protease inhibitor pharmacokinetics, including drug-drug and drug-food interactions and dosing information. Living Document: last updated 5 February 2001: www.hivatis.org.
2. Drusano GL, Bilello JA, Stein DS, et al.: Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables. J Infect Dis 1998, 178:360–367.
3. Moore RD, Chaisson RE: Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999, 13:1933–1942.
4. Wit FW, van Leeuwen R, Weverling GJ, et al.: Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons. J Infect Dis 1999, 179:790–798.
5. Paredes R, Mocroft A, Kirk O, et al.: Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med 2000, 160:1123–1132.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献